Astragaloside IV Regulates cGAS-STING Signaling Pathway to Alleviate Immunosuppression Caused by PRRSV Infection

Viruses. 2023 Jul 20;15(7):1586. doi: 10.3390/v15071586.

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) poses a global threat to pig health and results in significant economic losses. Impaired innate and adaptive immune responses are evident during PRRSV infection. Cyclic GMP-AMP synthase (cGAS), a classical pattern recognition receptor recognizing mainly intracytoplasmic DNA, induces type I IFN responses through the cGAS-STING signaling pathway. It has also been demonstrated that cGAS-STING is involved in PRRSV infection. This study utilized the qRT-PCR, ELISA, and WB methods to examine the effects of Astragaloside IV (AS-IV) on the regulation of innate immune function and cGAS-STING signaling pathway in porcine alveolar macrophages. The results showed that AS-IV attenuated the decreased innate immune function caused by PRRSV infection, restored the inhibited cGAS-STING signaling pathway, and increased the expression of interferon, ultimately exerting antiviral effects. Moreover, these results suggest that AS-IV may be a promising candidate for a new anti-PRRSV antiviral, and its mechanism of action may provide insights for developing novel antiviral agents.

Keywords: AS-IV; PRRSV; antiviral activity; cGAS-STING; immunosuppression.

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Immunity, Innate
  • Immunosuppression Therapy
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • Porcine respiratory and reproductive syndrome virus* / metabolism
  • Signal Transduction
  • Swine

Substances

  • astragaloside A
  • Nucleotidyltransferases
  • Antiviral Agents

Grants and funding

This research received no external funding.